MetaCap

Heron Therapeutics (HRTX) News

NASDAQ: HRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.2525-0.0116 (-4.39%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

HRTX news summary

We found 6 recent headlines mentioning Heron Therapeutics (HRTX): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, HRTX is down 4.39% at $0.2525. The most recent story, "CRMD to Acquire HRTX Assets for $223M Upfront to Expand Portfolio", was published by Nasdaq on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Heron Therapeutics headlines

Stocks mentioned alongside HRTX

Compare HRTX